I am a
Home I AM A Search Login

Papers of the Week

Papers: 4 Jan 2020 - 10 Jan 2020

Pharmacology/Drug Development

2020 04 01

Pain Med



Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.


Webster L, Gudin J, Raffa RB, Kuchera J, Rauck R, Fudin J, Adler J, Mallick-Searle T
Pain Med. 2020 04 01; 21(4):714-723.
PMID: 31917418.


An expert panel convened to reach a consensus on common misconceptions surrounding buprenorphine, a Schedule III partial µ-opioid receptor agonist indicated for chronic pain. The panel also provided clinical recommendations on the appropriate use of buprenorphine and conversion strategies for switching to buprenorphine from a full µ-opioid receptor agonist for chronic pain management.